Vesicular accumulation of the membrane component ceramide may underlie key aspects of lung pathology in cystic fibrosis (pages 382–391).
References
Teichgräber, V. et al. Nat. Med. 14, 382–391 (2008).
Grassme, H. et al. Nat. Med. 9, 322–330 (2003).
Campodonico, V.L., Gadjeva, M., Paradis-Bleau, C., Uluer, A. & Pier, G.B. Trends Mol. Med. 14, 120–133 (2008).
Schroeder, T.H. et al. J. Immunol. 166, 7410–7418 (2001).
Boucher, R.C. Eur. Respir. J. 23, 146–158 (2004).
Murphy, T.F. & Sethi, S. Drugs Aging 19, 761–775 (2002).
Guilbault, C. et al. Am. J. Respir. Cell Mol. Biol. 38, 47–56 (2008).
Di, A. et al. Nat. Cell Biol. 8, 933–944 (2006).
Haggie, P.M. & Verkman, A.S. J. Biol. Chem. 282, 31422–31428 (2007).
Poschet, J.F. et al. J. Biol. Chem. 277, 13959–13965 (2002).
Wood, D.M. & Smyth, A.R. Cochrane Database Syst. Rev. CD004197 (2006).
Donaldson, S.H. et al. N. Engl. J. Med. 354, 241–250 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pier, G. Dropping acid to help cystic fibrosis. Nat Med 14, 367–369 (2008). https://doi.org/10.1038/nm0408-367
Issue Date:
DOI: https://doi.org/10.1038/nm0408-367
- Springer Nature America, Inc.